ENXTPA:EXENSAerospace & Defense
Is Exosens (ENXTPA:EXENS) Undervalued On Raised 2026 Guidance?
Exosens raises 2026 guidance and sharpens investor focus
Exosens (ENXTPA:EXENS) lifted its full-year 2026 earnings guidance and now projects revenue between €558 million and €570 million, compared with an earlier range of €520 million to €540 million.
The upgraded outlook has quickly fed into the market reaction, with Exosens’ 1-day share price return of 8.37% lifting the stock to €58.9 and partly reversing a 30-day share price decline of 5.38% and a 90-day share price fall of 2.00%.
Even...